Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-01 @ 11:04 PM
Study NCT ID:
NCT01217892
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2010-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Dapagliflozin Taken Twice-daily
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1691C00003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |